Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells

<div>mRNA and the protein expression levels of <i>CCND1, SIRT2, AURKB, VEGFA, HDAC1, CASP9,</i><i>HSP90AA1</i>, and <i>HSP90AB1</i>. (a) mRNA expression levels in the Cancer Genome Atlas (TCGA). (b) Protein expression levels in normal and tumor breast tissues retrieved from the Human Protein Atlas (HPA).</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells 

Figure 4 | Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells 